halo top stock price

Top institutional investors include BlackRock Inc. (9.77%), William Blair Investment Management LLC (4.82%), State Street Corp (3.37%), Snyder Capital Management L P (2.50%), Third Security LLC (2.21%) and First Light Asset Management LLC (1.41%). Halozyme Therapeutics has received 53.28% “outperform” votes from our community. HALO Stock Summary. halo top stock are also included in the list of such companies. Company profile page for Eden Creamery LLC including stock price, company news, press releases, executives, board members, and contact information Among the technology companies in the top ten are Apple with an increase of 4,419 percent and Netflix with 2840 percent. Learn more. 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halozyme Therapeutics in the last year. Halozyme Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. Current Halo Platform (Halo Platform) price is 0.000131052 USD. HALO has a less percent of analysts bearish on the stock than 14.17% of Pharmaceutical Products stocks. Get short term trading ideas from the MarketBeat Idea Engine. The official website for Halozyme Therapeutics is www.halozyme.com. All Deals. Include out of stock. Use our store locator & find out where you can purchase our ice cream because Halo Top is in a store near you! In the past three months, Halozyme Therapeutics insiders have sold more of their company's stock than they have bought. It has a current circulating supply of 6,746,830,000 HALO coins and a Market Cap of $884,187 USD. Now it's being sold to one of the nation's biggest ice cream manufacturers, Wells Enterprises, owner of … © American Consumer News, LLC dba MarketBeat® 2010-2020. Halozyme Therapeutics, Inc. (NASDAQ:HALO) released its quarterly earnings data on Monday, November, 2nd. Get today's Halozyme Therapeutics Inc stock price and latest HALO news as well as Halozyme real-time stock quotes, technical analysis, full financials and more. Get short term trading ideas from the MarketBeat Idea Engine. For a wide assortment of Halo Top visit Target.com today. View which stocks are hot on social media with MarketBeat's trending stocks report. Learn more. Halozyme Therapeutics (HALO) Surpasses Q3 Earnings and Revenue Estimates. The biopharmaceutical company reported $0.25 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.20 by $0.05. 1 out of 5 & up & up. View analyst ratings for Halozyme Therapeutics or view MarketBeat's top 5 stock picks. Please log in to your account or sign up in order to add this asset to your watchlist. Halozyme Therapeutics, Inc. (HALO) stock is up 3.19% while the S&P 500 has fallen -1.63% as of 12:18 PM on Tuesday, Oct 20. Include out of stock. Halo Top ice cream became America's bestselling grocery store pint two years ago. Halo Platform stock price is down by (-2.44%) today.USD worth of Halo Platform (HALO) has been traded in the past 24 hours. The company provided earnings per share guidance of 0.90-0.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.86. halo stock price are also included in the list of such companies. Include out of stock. Only 2.60% of the stock of Halozyme Therapeutics is held by insiders. 4 out of 5 & up & up. Shipping & Pickup. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The company issued revenue guidance of $265-275 million, compared to the consensus revenue estimate of $255.12 million. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. During the same period in the prior year, the business earned ($0.17) EPS. Craving Halo Top, but not sure where to get it? ... Halo Top : Ice Cream & Frozen Dairy Desserts . Counsel, Chief Compliance Officer & Corp. Sec. See what's happening in the market right now with MarketBeat's real-time news feed. The biopharmaceutical company earns $-72,240,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Sr. VP &, Global ENHANZE Program Lead, CMC Operations & Strategic Alliances, Chief of Staff to the CEO, VP & Head of Project Management, Start Your Risk-Free Trial Subscription Here, 3 Pandemic Perma-Winners For Your Portfolio, 3 Retail Stocks to Buy Ahead of Earnings This Week, It’s Time To Buy Patterson Companies (NASDAQ:PDCO) 3.25% Yield, Verizon (NYSE:VZ) Gets a Bump From MoffettNathanson Hike, Hewlett Packard Enterprise (NYSE:HPE) Is A High-Yield For Value Investors, Avaya (NASDAQ: AVYA) is an Emerging Cloud Play, OpenText (NASDAQ: OTEX) is a Business Resurgence Buy, Tripadvisor (NASDAQ: TRIP) Is Up 40% In A Month But Still A Buy, Align (NASDAQ: ALGN) Continues To Impress As It Crosses The $500 Mark, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, Receive Analysts' Upgrades and Downgrades Daily. Discover historical prices for HALO stock on Yahoo Finance. Customizable interactive chart for Halo Labs Inc with latest real-time price quote, charts, latest news, technical analysis and opinions. Sign-up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Earlier, the stock roared as much as 14.9% to an all-time high of 32.62. Shop Target for Halo Top. The variance in analysts' estimates of HALO is lower than 8.23% of stocks in the mid market cap category. Halozyme Therapeutics does not currently pay a dividend. Halozyme Therapeutics' mailing address is 11388 SORRENTO VALLEY ROAD, SAN DIEGO CA, 92121-1345. Sort by Featured. Their forecasts range from $20.00 to $60.00. In the stock market today , HALO stock soared 11.3% to 31.62. This is usually characteristic of DISTRIBUTION; however, price did not close below support. (Add your “underperform” vote.). The company's low-fat and non-fat varieties of ice cream appeal to health and calorie conscious consumers and are made using organic and natural ingredients, enabling users to experience healthy variants of ice cream. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Post-Market 0.00 (0.00%) Analyzing Halozyme Therapeutics (NASDAQ:HALO) stock? Over the past year the S&P 500 is higher by 13.98% while HALO is higher by 98.17%. HALO stock was purchased by a variety of institutional investors in the last quarter, including First Light Asset Management LLC, AJO LP, Morgan Stanley, Oak Ridge Investments LLC, WINTON GROUP Ltd, Wells Fargo & Company MN, Lateef Investment Management L.P., and Voloridge Investment Management LLC. View all competitors. View which stocks have been most impacted by COVID-19. Halo Top General Information Description. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Halozyme Therapeutics, Inc. HALO 40.23 0.91 (2.21%). Do Not Sell My Information. High institutional ownership can be a signal of strong market trust in this company. How to buy halo top stock? Guest Rating. Stock analysis for Halozyme Therapeutics Inc (HALO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 3 out of 5 & up & up. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; and National Institute of Allergy and Infectious Diseases. With a price/sales ratio of 27.25, Halozyme Therapeutics Inc has a higher such ratio than 92.94% of stocks in our set. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Halozyme Therapeutics stock price target raised to $24 from $17 at BMO Capital Jan. 9, 2020 at 11:43 a.m. Export data to Excel for your own analysis. Manufacturer of ice cream intended for calorie-conscious consumers. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Identify stocks that meet your criteria using seven unique stock screeners. View our earnings forecast for Halozyme Therapeutics. The company's success grew in 2016 after a GQ writer wrote an article about eating nothing but the ice … HALO is higher by $0.94 from the previous closing price of $29.46 on volume of 1,562,055 shares. How to buy halo stock price? Receive a free world-class investing education from MarketBeat. Halozyme Therapeutics employs 132 workers across the globe. Halozyme Therapeutics has received 447 “outperform” votes. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ALXN1210 and ALXN1810 subcutaneous formulations; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." The P/E ratio of Halozyme Therapeutics is 254.13, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.86. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The company's average rating score is 2.82, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings. Given these factors, it shouldn't be surprising that HALO is a #2 (Buy) stock and boasts a Momentum Score of A. Include out of stock. Halozyme Therapeutics had a return on equity of 24.29% and a net margin of 10.78%. Your health & safety is our priority, and we're taking COVID-19 very seriously. The biopharmaceutical company had revenue of $65.30 million for the quarter, compared to analysts' expectations of $59.35 million. Halozyme Therapeutics has received a consensus rating of Buy. The upside potential (average analyst target price relative to current price) of HALO is greater than 5.71% of all US stocks. View HALO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. This suggests that the stock has a possible downside of 14.1%. Type. Based on aggregate information from My MarketBeat watchlists, some companies that other Halozyme Therapeutics investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Gilead Sciences (GILD), Athabasca Oil Co. (ATH.TO) (ATH), NIC (EGOV), Allergan (AGN) and AbbVie (ABBV). 94.69% of the stock of Halozyme Therapeutics is held by institutions. Shares of HALO can be purchased through any online brokerage account. Wall Street analysts have given Halozyme Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. Buy halo stock price you can from brokers or on specialized sites. Its proprietary product include Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration; to enhance the dispersion and absorption of other injected drugs in subcutaneous urography; and to improve resorption of radiopaque agents. View insider buying and selling activity for Halozyme Therapeutics. Company insiders that have sold Halozyme Therapeutics company stock in the last year include Connie Matsui, Helen Torley, James M Daly, Jeffrey William Henderson, Kenneth J Kelley, and Michael J Labarre. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Their average twelve-month price target is $34.91, predicting that the stock has a possible downside of 15.15%. Your health & safety is our priority, and we're taking COVID-19 very seriously. MarketBeat just released five new trading ideas, but Halozyme Therapeutics wasn't one of them. This is a signs that BULLS are attempting to "absorb" supply. Specifically, they have bought $0.00 in company stock and sold $5,450,000.00 in company stock. 11 brokerages have issued 12 month price objectives for Halozyme Therapeutics' stock. Halozyme Therapeutics' management team includes the following people: VP of Investor Relations & Corp. Communications. Company insiders that own Halozyme Therapeutics stock include Connie Matsui, Dimitrios Chondros, Helen Torley, James M Daly, Jeffrey William Henderson, Kenneth J Kelley and Michael J Labarre. Halozyme Therapeutics trades on the NASDAQ under the ticker symbol "HALO.". Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Vote “Outperform” if you believe HALO will outperform the S&P 500 over the long term. He rates HALO stock as market outperform, with a 34 price target. View analysts' price targets for Halozyme Therapeutics. The company is also developing Perjeta for breast cancer; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. Halozyme Therapeutics's revenue for the quarter was up 41.3% compared to the same quarter last year. View institutional ownership trends for Halozyme Therapeutics. Find real-time HALO - Halozyme Therapeutics Inc stock quotes, ... Gilead (GILD) Reports Positive Top-Line Data on HIV Candidate. The biopharmaceutical company can be reached via phone at 858-794-8889 or via email at [email protected]. ), Halozyme Therapeutics has received 392 “underperform” votes. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. $0 – $15. (Add your “outperform” vote. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. © 2020 Verizon Media. The P/E ratio of Halozyme Therapeutics is 254.13, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.91. A Halo Top serving has 240 … Does Halozyme Therapeutics (HALO) have what it takes to be a top stock pick for momentum investors? Since then, HALO shares have increased by 123.2% and is now trading at $40.66. 2 out of 5 & up & up. Halo Top generated $132.4 million in sales last year, according to data from IRI. Get daily stock ideas top-performing Wall Street analysts. Halozyme Therapeutics' stock is owned by a number of institutional and retail investors. What's next for the stock? All rights reserved. Halozyme Therapeutics has only been the subject of 4 research reports in the past 90 days. Halo Top is light ice cream that actually tastes like ice cream. A high-level overview of Halozyme Therapeutics, Inc. (HALO) stock. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. 40.60 -0.06 (-0.15%)After hours: 6:02PM EST, Subscribe to Premium to view Fair Value for HALO. On average, they expect Halozyme Therapeutics' share price to reach $34.91 in the next year. Halozyme Therapeutics (HALO) reported earnings 30 days ago. MarketBeat's community ratings are surveys of what our community members think about Halozyme Therapeutics and other stocks. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Let's find out. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Sale. Halozyme Therapeutics' stock was trading at $18.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Halozyme (HALO) Q3 Earnings Top, 2020 View Up, Stock Rises Zacks Equity Research November 03, 2020 JNJ Quick Quote JNJ RHHBY Quick Quote RHHBY HALO Quick Quote HALO ARGX Quick Quote … The high price target for HALO is $60.00 and the low price target for HALO is $20.00. Pre-Market earnings guidance on Monday, November, 23rd. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. Halozyme Therapeutics issued an update on its FY 2020 Vote “Underperform” if you believe HALO will underperform the S&P 500 over the long term. ... Price. View daily, weekly or … HALO's current price/earnings ratio is 252.67, which is higher than 96.96% of US stocks with positive earnings. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Morningstar and Zacks Investment Research. View our full suite of financial calendars and market data tables, all for free. Halo Platform Statistics. Halozyme Therapeutics has a P/B Ratio of 55.70. This is because demand exceeded supply. Zacks' 7 Best Strong Buy Stocks for December, 2020. Halo Companies Inc (HALN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Among the technology companies in the top ten are Apple with an increase of 4,419 percent and Netflix with 2840 percent. You may vote once every thirty days. $0 – $15 $ to $$$ apply. Some companies that are related to Halozyme Therapeutics include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Incyte (INCY), Exact Sciences (EXAS), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Novavax (NVAX) and Ionis Pharmaceuticals (IONS).

Suzuki Vitara 2 Door For Sale, Fraser Property Management, Beaverton School District Salary Schedule 2020-2021, Best Books To Resell, Godzilla Vs Dogora,

Вашият коментар

Вашият имейл адрес няма да бъде публикуван. Задължителните полета са отбелязани с *

Можете да използвате тези HTML тагове и атрибути: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

CommentLuv badge